ECSP055669A - DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONIC - Google Patents
DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONICInfo
- Publication number
- ECSP055669A ECSP055669A EC2005005669A ECSP055669A ECSP055669A EC SP055669 A ECSP055669 A EC SP055669A EC 2005005669 A EC2005005669 A EC 2005005669A EC SP055669 A ECSP055669 A EC SP055669A EC SP055669 A ECSP055669 A EC SP055669A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- chronic
- ischemical
- pyrimidinone
- acute
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención trata de nuevos derivados heterocíclicos, procedimientos para su preparación y su uso en medicamentos, especialmente para el tratamiento de enfermedades pulmonares obstructivas crónicas.The invention concerns new heterocyclic derivatives, methods for their preparation and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0220962A GB0220962D0 (en) | 2002-09-10 | 2002-09-10 | Heterocyclic derivatives |
GB0226609A GB0226609D0 (en) | 2002-09-10 | 2002-11-14 | Heterocyclic derivatives |
GB0315870A GB2392910A (en) | 2002-09-10 | 2003-07-07 | 2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP055669A true ECSP055669A (en) | 2005-05-30 |
Family
ID=39827677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2005005669A ECSP055669A (en) | 2002-09-10 | 2005-03-10 | DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONIC |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP4708034B2 (en) |
AR (1) | AR042179A1 (en) |
EC (1) | ECSP055669A (en) |
ES (1) | ES2414865T3 (en) |
GB (1) | GB2392910A (en) |
HK (1) | HK1088304A1 (en) |
PE (1) | PE20041078A1 (en) |
TW (1) | TWI314555B (en) |
UA (1) | UA82074C2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03008714A (en) | 2002-09-26 | 2004-09-10 | Oreal | Sequenced polymers and cosmetic compositions comprising the same. |
JP3981130B2 (en) * | 2002-09-26 | 2007-09-26 | ロレアル | Migration resistant cosmetic composition comprising a sequence polymer |
SE0302486D0 (en) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
FR2860143B1 (en) | 2003-09-26 | 2008-06-27 | Oreal | COSMETIC COMPOSITION COMPRISING A SEQUENCE POLYMER AND A NON-VOLATILE SILICONE OIL |
EP1723121B1 (en) * | 2004-02-26 | 2012-07-25 | Bayer Pharma Aktiengesellschaft | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
US7893073B2 (en) * | 2004-02-26 | 2011-02-22 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclic derivatives |
TW200808763A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds I |
TW200808771A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds II |
FR2904320B1 (en) | 2006-07-27 | 2008-09-05 | Oreal | POLYMER SEQUENCES, AND PROCESS FOR THEIR PREPARATION |
US20110003858A1 (en) * | 2006-09-04 | 2011-01-06 | Bergstroem Lena | Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
EP2217591A4 (en) | 2007-11-06 | 2011-10-26 | Astrazeneca Ab | Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
MY150285A (en) * | 2007-12-20 | 2013-12-31 | Bayer Ip Gmbh | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
DE102008022521A1 (en) * | 2008-05-07 | 2009-11-12 | Bayer Schering Pharma Aktiengesellschaft | 1,4-Diaryl-pyrimidopyridazine-2,5-diones and their use |
WO2009149836A1 (en) * | 2008-06-09 | 2009-12-17 | Bayer Schering Pharma Aktiengesellschaft | Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof |
TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
DE102009016553A1 (en) * | 2009-04-06 | 2010-10-07 | Bayer Schering Pharma Aktiengesellschaft | Sulfonamide- and sulfoximine-substituted diaryldihydropyrimidinones and their use |
KR20120099639A (en) | 2009-10-02 | 2012-09-11 | 아스트라제네카 아베 | 2-pyridone compounds used as inhibitors of neutrophil elastase |
US20140221335A1 (en) | 2013-02-06 | 2014-08-07 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9115093B2 (en) | 2013-03-04 | 2015-08-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
USRE47493E1 (en) | 2014-02-20 | 2019-07-09 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9657015B2 (en) | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9458113B2 (en) | 2014-07-31 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9290457B2 (en) | 2014-07-31 | 2016-03-22 | Boehringer Ingelheim International Gmbh | Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9440930B2 (en) * | 2014-07-31 | 2016-09-13 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
-
2003
- 2003-07-07 GB GB0315870A patent/GB2392910A/en not_active Withdrawn
- 2003-08-27 AR ARP030103093A patent/AR042179A1/en unknown
- 2003-08-28 ES ES03773613T patent/ES2414865T3/en not_active Expired - Lifetime
- 2003-08-28 UA UAA200503292A patent/UA82074C2/en unknown
- 2003-08-28 JP JP2004571738A patent/JP4708034B2/en not_active Expired - Fee Related
- 2003-09-09 PE PE2003000910A patent/PE20041078A1/en not_active Application Discontinuation
- 2003-09-09 TW TW092124801A patent/TWI314555B/en not_active IP Right Cessation
-
2005
- 2005-03-10 EC EC2005005669A patent/ECSP055669A/en unknown
-
2006
- 2006-07-31 HK HK06108489.5A patent/HK1088304A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB0315870D0 (en) | 2003-08-13 |
TWI314555B (en) | 2009-09-11 |
JP4708034B2 (en) | 2011-06-22 |
TW200410963A (en) | 2004-07-01 |
GB2392910A (en) | 2004-03-17 |
AR042179A1 (en) | 2005-06-15 |
HK1088304A1 (en) | 2006-11-03 |
PE20041078A1 (en) | 2005-02-25 |
JP2006507355A (en) | 2006-03-02 |
ES2414865T3 (en) | 2013-07-23 |
UA82074C2 (en) | 2008-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055669A (en) | DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONIC | |
UY27965A1 (en) | HETEROCYCLIC DERIVATIVES | |
BRPI0407234A (en) | Substituted heterocycles | |
CY1120741T1 (en) | TREATMENT OF NOSE SCRUB | |
CR7043A (en) | DERIVATIVES OF USEFUL ETERES AS INHIBITING GANETS OF THE ISOZIMAS PDE4 | |
HN2001000019A (en) | DERIVATIVES OF NICOTINAMIDE BENZOCONDENSADA HETEROCICLICO USEFUL AS SELECTIVE INHIBITORS OF THE ISOZIMAS PDE4. | |
CL2008003096A1 (en) | Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others. | |
IS7840A (en) | 3- (3,5-Dioxo-4,5-dihydro-3H- (1,2,4) triazin-2-yl) -benzamide derivatives as P2X7 inhibitors for use in the treatment of inflammatory diseases | |
ECSP056138A (en) | SUBSTITUTED DIHYDROQUINAZOLINS | |
CR20110608A (en) | DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA | |
CY1108932T1 (en) | Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases | |
CY1105080T1 (en) | THIENOPYRROLYL AND FURANOPYRROLYL COMPOUNDS AND THEIR USE AS H4 HISTAMINE RECEPTOR BINDERS | |
ECSP088821A (en) | THIOXANTINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MPO | |
PA8720801A1 (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF DEPRESSION | |
CY1111656T1 (en) | Alpha-Aminoamide Derivatives Useful in the Therapeutic Treatment of Addictive Diseases | |
CL2007002689A1 (en) | COMPOUNDS DERIVED FROM PIPERIDIN-1-CARBOXAMIDA, INHIBITORS OF THE RENINE; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS HYPERTENSION, CARDIAC INSUFFICIENCY, CARDIAC FIBROSIS, AMONG OTHERS. | |
CL2007002384A1 (en) | Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis. | |
CO5700775A2 (en) | NEW TRICYCLE DERIVATIVES AS AN ANTAGONISTS OF LTD4 | |
MX2009004017A (en) | The uses of the carboxy-amido-triazole compounds and salts thereof. | |
GT200500266A (en) | NEW DERIVATIVES OF PYRIMIDINE AND ITS USE | |
CY1116840T1 (en) | USE 24-NORUDCA | |
NO20074780L (en) | Heterocyclylamide-substituted imidazoles | |
IS7444A (en) | Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases | |
BRPI0518700B8 (en) | combination containing vegf-trap, 5-fluorouracil and folinic acid | |
EA201070195A1 (en) | DERIVATIVES 1,2,3,4-TETRAGIDROPYRROLO [1,2-A] PIRAZIN-6-CARBOXAMIDES AND 2,3,4,5-TETRAHYDROPYRROLO [1,2-a] [1,4] -DIAZEPIN-7-CARBOXAMIDES , THEIR RECEIVING AND THEIR APPLICATION IN THERAPY |